Brookline Capital Acquisition Corp (BCAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAC | AZN | AMGN | GILD | BMY |
| Company | Brookline Capital Acquisition Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.07 | 188.26 | 340.56 | 135.25 | 59.62 |
| High | 27.74 | 188.61 | 342.49 | 136.32 | 59.78 |
| Low | 9.94 | 186.92 | 335.20 | 134.29 | 58.07 |
| Latest | 22.71 | 187.03 | 335.26 | 134.70 | 58.13 |
| Change | +12.63 | +0.38 | -4.04 | +0.34 | -1.33 |
| % Change | +125.30% | +0.20% | -1.19% | +0.25% | -2.24% |
| Volume | 586,400 | 1,009,174 | 886,244 | 3,727,983 | 4,571,756 |
| 20-Day Average Volume | 69,480 | 1,993,772 | 2,697,700 | 6,004,401 | 10,113,111 |
| Previous Close | 10.08 | 187.03 | 339.30 | 134.36 | 59.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 184.98 | 333.16 | 132.10 | 57.58 |
| 20-Day Raw Stochastic | 72.42% | 62.39% | 53.14% | 70.96% | 51.44% |
| 20-Day Relative Strength | 93.64 | 47.68 | 47.30 | 50.64 | 50.25 |
| Weighted Alpha | +26.80 | +24.02 | +13.73 | +19.88 | +22.02 |
| Today's Opinion | 100% Buy | Hold | 8% Sell | 8% Buy | 32% Buy |
| Previous Opinion | 40% Buy | 8% Sell | 8% Sell | 8% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 48% Buy | 8% Buy | 8% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +130.09% since 07/22/22 | +1.77% since 05/18/26 | +3.56% since 05/18/26 | +3.90% since 05/18/26 | +1.50% since 05/18/26 |
| Low | 9.68 on 07/25/22 | 184.19 on 05/19/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 57.08 on 05/19/26 |
| High | 27.74 on 07/29/22 | 191.50 on 05/21/26 | 343.80 on 05/22/26 | 136.15 on 05/26/26 | 60.25 on 05/22/26 |
| 1-Month | |||||
| %Chg | +123.52% since 06/29/22 | -1.36% since 04/24/26 | -2.50% since 04/24/26 | +3.32% since 04/24/26 | -0.92% since 04/24/26 |
| Low | 9.50 on 07/22/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 27.74 on 07/29/22 | 191.50 on 05/21/26 | 349.54 on 04/30/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +124.52% since 04/29/22 | -8.24% since 02/26/26 | -11.44% since 02/26/26 | -6.29% since 02/26/26 | -4.80% since 02/26/26 |
| Low | 9.50 on 07/22/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 27.74 on 07/29/22 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +127.10% since 01/28/22 | +0.29% since 11/26/25 | -2.50% since 11/26/25 | +5.66% since 11/26/25 | +18.11% since 11/26/25 |
| Low | 9.50 on 07/22/22 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 27.74 on 07/29/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 153,204 | 290,066,304 | 183,115,120 | 166,817,344 | 121,421,536 |
| Shares Outstanding, K | 6,746 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -2,457,658 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | -0.03 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/23/22 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 01/01/70 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.49 | 15.27 | 15.59 | 10.04 |